|
Q1 FY2021
As of Jan 1, 2021
|
Q4 FY2020
As of Oct 2, 2020
|
Q3 FY2020
As of Jul 3, 2020
|
Q2 FY2020
As of Apr 3, 2020
|
Q1 FY2020
As of Jan 3, 2020
|
Q4 FY2019
As of Sep 27, 2019
|
Q3 FY2019
As of Jun 28, 2019
|
Q2 FY2019
As of Mar 29, 2019
|
Q1 FY2019
As of Dec 28, 2018
|
Q4 FY2018
As of Sep 28, 2018
|
Q3 FY2018
As of Jun 29, 2018
|
Q2 FY2018
As of Mar 30, 2018
|
Q1 FY2018
As of Dec 29, 2017
|
Q4 FY2017
As of Sep 29, 2017
|
Q3 FY2017
As of Jun 30, 2017
|
Q2 FY2017
As of Mar 31, 2017
|
Q1 FY2017
As of Dec 30, 2016
|
Q4 FY2016
As of Sep 30, 2016
|
Q3 FY2016
As of Jul 1, 2016
|
Q2 FY2016
As of Apr 1, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade and unbilled receivables, less allowance for credit losses of $55.2 and $52.3 at January 1, 2021 and October 2, 2020, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Deferred revenues | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Long-term lease liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Preferred stock of $1 par value: 1.0 shares authorized; none issued and outstanding | ||||||||||||||||||||
| Common stock of $1 par value: 189.0 shares authorized; 91.8 and 91.2 shares issued and outstanding at January 1, 2021 and October 2, 2020, respectively | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Varian stockholders' equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
